Signaling Pathway Mediating Myeloma Cell Growth and Survival

Signaling Pathway Mediating Myeloma Cell Growth and Survival

The multiple myeloma (MM) bone marrow (BM) microenvironment consists of different types of accessory cells. Both soluble factors (i.e., cytokines) secreted from these cells and adhesion of MM cells to these cells play crucial roles in activation of intracellular signaling pathways mediating MM cell...

Full description

Bibliographic Details
Main Authors:	Teru Hideshima, Kenneth C. Anderson
Format:	Article
Language:	English
Published:	MDPI AG 2021-01-01
Series:	Cancers
Subjects:	multiple myeloma bone marrow microenvironment cytokine cell adhesion signal transduction
Online Access:	https://www.mdpi.com/2072-6694/13/2/216

Similar Items

Cytokine-Mediated Dysregulation of Signaling Pathways in the Pathogenesis of Multiple Myeloma
by: Sabah Akhtar, et al.
Published: (2020-07-01)

The Role of Marrow Microenvironment in the Growth and Development of Malignant Plasma Cells in Multiple Myeloma
by: Nikolaos Giannakoulas, et al.
Published: (2021-04-01)

Bone Marrow Microenvironment Interplay and Current Clinical Practice in Multiple Myeloma: A Review of the Balkan Myeloma Study Group
by: Jelena Bila, et al.
Published: (2021-08-01)

The Route of the Malignant Plasma Cell in Its Survival Niche: Exploring “Multiple Myelomas”
by: Antonio Giovanni Solimando, et al.
Published: (2022-07-01)

Boosting Immunity against Multiple Myeloma
by: Raquel Lopes, et al.
Published: (2021-03-01)

Investigating the Interplay between Myeloma Cells and Bone Marrow Stromal Cells in the Development of Drug Resistance: Dissecting the Role of Epigenetic Modifications
by: Jacqueline Schütt, et al.
Published: (2021-08-01)

The Role of Tumor Microenvironment in Multiple Myeloma Development and Progression
by: Almudena García-Ortiz, et al.
Published: (2021-01-01)

Non-Toxicological Role of Aryl Hydrocarbon Receptor in Obesity-Associated Multiple Myeloma Cell Growth and Survival
by: Jonathan D. Diedrich, et al.
Published: (2023-11-01)

Role of protein kinases CK1α and CK2 in multiple myeloma: regulation of pivotal survival and stress-managing pathways
by: Sabrina Manni, et al.
Published: (2017-10-01)

Multiple myeloma presenting with coexisting severe marrow hypoplasia
by: Medhi K, et al.
Published: (2008-10-01)

Role of Extracellular Vesicle-Based Cell-to-Cell Communication in Multiple Myeloma Progression
by: Ilaria Saltarella, et al.
Published: (2021-11-01)

Role of Sphingolipids in Multiple Myeloma Progression, Drug Resistance, and Their Potential as Therapeutic Targets
by: Daniela N. Petrusca, et al.
Published: (2022-06-01)

Study on the Mechanisms of Multiple Myeloma Cells Promoting M2 Macrophage Polarization through PI3K/AKT Signaling Pathway
by: PENG Yilun, LI Yang, WANG Xiaotao
Published: (2024-03-01)

The Lipoprotein Transport System in the Pathogenesis of Multiple Myeloma: Advances and Challenges
by: Vasileios Lazaris, et al.
Published: (2021-03-01)

The role of bone marrow microenvironment in the progression of multiple myeloma from monoclonal gammopathy of undetermined significance
by: A. S. Khudovekova, et al.
Published: (2021-09-01)

Ferritin Metabolism Reflects Multiple Myeloma Microenvironment and Predicts Patient Outcome
by: Federica Plano, et al.
Published: (2023-05-01)

Desmoglein‐2 expression is an independent predictor of poor prognosis patients with multiple myeloma
by: Lisa M. Ebert, et al.
Published: (2022-03-01)

Variability of serum novel serum peptide biomarkers correlates with the disease states of multiple myeloma
by: Ju Bai, et al.
Published: (2019-04-01)

Bone Marrow Mesenchymal Stromal Cells in Multiple Myeloma: Their Role as Active Contributors to Myeloma Progression
by: Patricia Maiso, et al.
Published: (2021-05-01)

Game of Bones: How Myeloma Manipulates Its Microenvironment
by: Tyler Moser-Katz, et al.
Published: (2021-02-01)

Novel Developments in the Treatment of Multiple Myeloma-Associated Bone Disease
by: Martin Johansen, et al.
Published: (2023-11-01)

CHARACTERISTICS OF BONE MARROW MICROENVIRONMENT IN MULTIPLE MYELOMA BEFORE AND AFTER TREATMENT
by: V. I. Rugal, et al.
Published: (2019-03-01)

High Expression of the Costimulatory Checkpoint Factor DNAM-1 by CD4+ T-Cells from Multiple Myeloma Patients Refractory to Daratumumab-Containing Regimens
by: Katrine Fladeland Iversen, et al.
Published: (2022-08-01)

Relationship Between Serum Periostin Level and Bone Marrow Fibrosis in Newly Diagnosed Multiple Myeloma Patients
by: Ali Kürşat TUNA, et al.
Published: (2023-06-01)

Multiple Myeloma Derived Extracellular Vesicle Uptake by Monocyte Cells Stimulates IL-6 and MMP-9 Secretion and Promotes Cancer Cell Migration and Proliferation
by: Rebecca Sheridan, et al.
Published: (2024-02-01)

DCZ0814 induces apoptosis and G0/G1 phase cell cycle arrest in myeloma by dual inhibition of mTORC1/2
by: Kong Y, et al.
Published: (2019-05-01)

Can Targeting Hypoxia-Mediated Acidification of the Bone Marrow Microenvironment Kill Myeloma Tumor Cells?
by: Gilberto Gastelum, et al.
Published: (2021-07-01)

MORPHOLOGICAL FEATURES OF TUMORS SUBSTRATE IN MULTIPLE MYELOMA PATIENTS COMPLICATED WITH PLASMACYTOMA
by: M. V. Firsova, et al.
Published: (2018-07-01)

Systemic Mastocytosis Associated with “Smoldering” Multiple Myeloma
by: Magda Zanelli, et al.
Published: (2021-01-01)

HB-EGF–EGFR Signaling in Bone Marrow Endothelial Cells Mediates Angiogenesis Associated with Multiple Myeloma
by: Luigia Rao, et al.
Published: (2020-01-01)

CD200 genotype is associated with clinical outcome of patients with multiple myeloma
by: Yolanda Gonzalez-Montes, et al.
Published: (2024-02-01)

Targeting Multiple Myeloma through the Biology of Long-Lived Plasma Cells
by: Adam Utley, et al.
Published: (2020-07-01)

Potential Role of microRNAs in inducing Drug Resistance in Patients with Multiple Myeloma
by: Alessandro Allegra, et al.
Published: (2021-02-01)

Ex Vivo Models Simulating the Bone Marrow Environment and Predicting Response to Therapy in Multiple Myeloma
by: Konstantinos Papadimitriou, et al.
Published: (2020-07-01)

Treating Multiple Myeloma in the Context of the Bone Marrow Microenvironment
by: Matthew Ho, et al.
Published: (2022-11-01)

Survival in patients with multiple myeloma: evaluation of possible associations with bone marrow fibrosis and investigation of factors independently associated with survival
by: Esma Evrim Dogan, et al.
Published: (2022-09-01)

Past, Present, and a Glance into the Future of Multiple Myeloma Treatment
by: Weam Othman Elbezanti, et al.
Published: (2023-03-01)

Deep Phenotyping Reveals Distinct Immune Signatures Correlating with Prognostication, Treatment Responses, and MRD Status in Multiple Myeloma
by: Konstantinos Papadimitriou, et al.
Published: (2020-11-01)

CK1α/RUNX2 Axis in the Bone Marrow Microenvironment: A Novel Therapeutic Target in Multiple Myeloma
by: Anna Fregnani, et al.
Published: (2022-08-01)

The role of lymphoid tissue SPARC in the pathogenesis and response to treatment of multiple myeloma
by: Nesreen Amer Ramadan Aly, et al.
Published: (2022-12-01)